High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue
Reference (28)
- et al.
High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains
Eur. J. Pharmacol.
(1985) - et al.
Characterization of [3H]paroxetine binding to rat cortical membranes
Eur. J. Pharmacol.
(1985) - et al.
Binding of a specific 5-HT uptake inhibitor3H-norzimeldine to rat brain homogenates
Eur. J. Pharmacol.
(1982) - et al.
The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brain
Neurochem. Int.
(1987) Differentiation of two components of specific [3H]imipramine binding in rat brain
Eur. J. Pharmacol.
(1984)Inhibition of sodium dependent [3H]-imipramine binding in rat brain by serotonin and serotonin uptake inhibitors
Eur. J. Pharmacol.
(1988)- et al.
LIGAND: a versatile computerized approach for characterization of ligand-binding systems
Anal. Biochem.
(1980) The CNS serotonergic system: progression toward a colloborative organization
- et al.
5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. I. Characteristics
Brain Research
(1987) - et al.
Quantitative autoradiography of [3H]indalpine binding sites in the rat brain. I. Pharmacological characterization
J. Neurochem.
(1985)
High- and low affinity binding components for [3H]imipramine in rat cerebral cortex
J. Neurochem.
Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple binding sites by [3H]imipramine
J. Pharmacol. Exp. Ther.
Aminergic systems in Alzheimer's disease and Parkinson's disease
Ann. Neurol.
Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study
Psychopharmacology
Cited by (162)
A systematic review of blood-based serotonergic biomarkers in Bulimia Nervosa
2019, Psychiatry ResearchCitation Excerpt :MAO activity in BN was also found to differ from HC, especially, when there were signs of impulsivity and suicidality (Carrasco et al., 2000) (Table 4). Platelet [3H]paroxetine binding is a marker for the 5-HT uptake site in the human brain (Backstrom et al., 1989). Although this is a peripheral measure, there is good evidence that it indirectly measures the activity of the central SERT protein (Mellerup et al., 1983) as assessed by density of receptors (B-max), and by binding affinity of the drug at the receptor site (Kd).
Alcohol and violence in psychopathy and antisocial personality disorder: Neural mechanisms
2019, Neuroscience of Alcohol: Mechanisms and TreatmentTest-retest reproducibility of extrastriatal binding with <sup>123</sup>I-FP-CIT SPECT in healthy male subjects
2016, Psychiatry Research - NeuroimagingDopamine and serotonin transporter availability in chronic heroin users: A [<sup>123</sup>I]β-CIT SPECT imaging study
2010, Psychiatry Research - NeuroimagingDiencephalic Serotonin Transporter Availability Predicts Both Transporter Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers
2009, Biological PsychiatryCitation Excerpt :Values of both cerebellar ROIs in three consecutive axial slices of maximal cerebellar activity were averaged. Cerebellar activity was assumed to represent nonspecific bound and free activity because it is known that the density of DAT and SERT in the cerebellum is very low (45,46). Ratios between mean counts in the target region (thalamus and hypothalamus) and the cerebellum were calculated.